Heterogeneity of demyelination in multiple sclerosis and clinical differences
Wender, M.ła.
Neurologia i Neurochirurgia Polska 38(2): 123-125
2004
ISSN/ISBN: 0028-3843 PMID: 15307605 Document Number: 567335
Recent studies of demyelination in multiple sclerosis revealed four different patterns, which led to the assumption of disease heterogeneity, but without evident correlation with clinical and neuroimaging picture. Therefore at present it seems too early to conclude that multiple sclerosis is not a uniform entity, but a group of different diseases.
Document emailed within 1 workday
Related Documents
Raine, C.S. 1984: Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis Laboratory Investigation; a Journal of Technical Methods and Pathology 50(6): 608-635Borhani-Haghighi, A.; Ghodsi, M.; Razeghinejad, M.R.; Mardani, S.; Mardani, M.; Nikseresht, A.R.; Safari, A.; Bagheri, M.H. 2012: Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event Neurosciences 17(2): 151-155
Stefferl, A.; Brehm, U.; Linington, C. 2000: The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis Journal of Neural Transmission. Supplementum 2000(58): 123-133
Bajramović, J.J.; Plomp, A.C.; Goes, A.v.; Koevoets, C.; Newcombe, J.; Cuzner, M.L.; van Noort, J.M. 2000: Presentation of alpha B-crystallin to T cells in active multiple sclerosis lesions: an early event following inflammatory demyelination Journal of Immunology 164(8): 4359-4366
Fernández-Muñoz, R.; Celma-Serrat, M. 2002: Virus and demyelination: why suspect that a virus may be involved in the aetiology of multiple sclerosis? Revista de Neurologia 35(10): 964-972
Bisaccia, G.; Caputo, D.; Landoni, A.M.; Macchi, G.P. 1978: Heterogeneity of human T lymphocytes to bind sheep red blood cells in multiple sclerosis patients and controls Bollettino dell'Istituto Sieroterapico Milanese 56(6): 603-608
Lopez-Alava, S.; Aliri, J.; Olascoaga, J.; Sistiaga, A. 2017: Psychosocial factors and cognitive performance in multiple sclerosis: gender differences Revista de Neurologia 65(5): 216-222
Ferrante, L.; Mastronardi, L.; Bardella, L. 1986: Acute cerebral multiple sclerosis: importance of a multiple diagnostic approach. Clinical case Rivista di Neurologia 56(6): 347-357
Schanke, A.K.; Grimsmo, J.; Sundet, K. 1995: Multiple sclerosis and prerequisites for driver's licence. A retrospective study of 33 patients with multiple sclerosis assessed at Sunnaas hospital Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(11): 1349-1352
Bykova, O.V.; Nankina, I.A.; Platonova, A.N.; Karpacheva, N.G.; Petrova, O.A.; Gorina, T.P.; Batysheva, T.T.; Serkov, S.V.; Kuzenkova, L.M. 2013: Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10 Pt 2): 61-68
Laosanguanek, N.; Wiroteurairuang, T.; Siritho, S.; Prayoonwiwat, N. 2011: Reliability of the Thai version of SF-36 questionnaire for an evaluation of quality of life in multiple sclerosis patients in multiple sclerosis clinic at Siriraj Hospital Journal of the Medical Association of Thailand 94 Suppl. 1: S84-S88
Reclos, G.J.; Baxevanis, C.N.; Sfagos, C.; Papageorgiou, C.; Tsokos, G.C.; Papamichail, M. 1987: Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis Clinical and Experimental Immunology 70(2): 336-344
Marchenkova, R.L.; Komandenko, N.I.; Skoromets, A.A. 1977: Various mechanisms of demyelination process in disseminated sclerosis Klinicheskaia Meditsina 55(9): 129-132
Saida, T. 2004: Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis Rinsho Shinkeigaku 44(11): 796-798
Bornstein, M.B.; Miller, A.; Slagle, S.; Weitzman, M.; Crystal, H.; Drexler, E.; Keilson, M.; Merriam, A.; Wassertheil-Smoller, S.; Spada, V. 1988: Clinical experience with COP-1 in multiple sclerosis Neurology 38(7 Suppl 2: 66-69
Matcău, L.; Sofletea, A.; Minciu, E.; Marcovici, H.; Creţu, M. 1968: Clinical aspects of multiple sclerosis Neurologia Psihiatria Neurochirurgia 13(6): 493-502
Zhao, B.X.; Liu, X.Q.; Guo, Y.P.; Yang, Y.C.; Huang, H.F. 1980: Multiple sclerosis: a clinical study of 70 cases Chinese Medical Journal 93(4): 260-264
Cendrowski, W. 1980: Criteria of clinical diagnosis of multiple sclerosis Neurologia i Neurochirurgia Polska 14(4): 445-448
Grimaud, J.; Pageot, N.; Rovaris, M. 2001: Parallels between clinical aspects and MRI in multiple sclerosis Revue Neurologique (Paris) 157(8-9 Part 1): 884-890
Brosnan, C.F.; Stoner, G.L.; Bloom, B.R.; Wisniewski, H.M. 1977: Studies on demyelination by activated lymphocytes in the rabbit eye. II. Antibody-dependent cell-mediated demyelination Journal of Immunology 118(6): 2103-2110